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ABSTRACT Monofloral heather (Erica sp.) honey samples (n = 89), harvested in Portugal according to European organic
beekeeping rules, were analyzed to test their antifungal effect against Candida albicans, Candida krusei, and Cryptococcus
neoformans. A synthetic honey solution was also tested to determine antifungal activity attributable to sugars. The specific
growth rate (l) values showed that growth of all the yeasts was reduced in the presence of honey. The honey concentration (%
wt/vol) that inhibited 10% of the yeast growth (Xmin) was 13.5% for C. albicans, 20.5% for C. krusei, and 17.1% for C.
neoformans. The respective concentrations of heather honey and synthetic honey in the C. krusei culture medium above 60%
(wt/vol) that inhibited 90% of the yeast growth (Xmax) and Xmin, respectively, were established, whereas C. albicans and C.
neoformans were more resistant because Xmax values were not reached over the range tested (10–60%, wt/vol). Heather honey
might be tapped as a natural resource to look for new medicines for the treatment of mycotic infections. Further studies are
now required to demonstrate if this antifungal activity has any clinical application.
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INTRODUCTION
The fact that Hippocrates, the father of medicine,emphasized the pharmaceutical value of honey is not
accidental. When analyzing and studying the therapeutic
properties of honeys, modern science has made it possible to
specify their medical significance as bactericidal, bacterio-
static, antiviral, antioxidant, anti-inflammatory, and antitu-
moral.1–3 Very few attempts have been made to date to
assess the antifungal properties of honey4–8 if we compare
these findings with the large volume of published literature
that has established that honey has significant antibacterial
activity.
Although all honeys have a common composition with a
high sugar content, low moisture, and acidity that prevents
microbial growth, ancient physicians were selective as to
which honeys they included in their remedies. In fact, in the
last decade, research indicates that honey quality and health
properties depend largely on the floral source,9 together with
other factors such as climatic conditions, soil type, and
beekeeper activities.10 In any case, concerns about traces of
numerous toxic substances have brought about a certain
demand for honey that is certified as being organic.11
Organic honeys are produced using strict ecological and
natural principles that are meant to enhance the good quality
of the honey harvested, and they are free from many prob-
lems associated with honey from other parts of the world,
such as pollution fallout and chemical residues.12 Honeys to
be used for therapeutic purposes should be harvested in
areas with no contamination sources.
The incidence of fungal infections is increasing in com-
munity and hospital environments,13 and no other mycotic
pathogen produces a spectrum of opportunistic diseases in
humans and animals as Candida does.14,15 Furthermore, the
rate of candidemia caused by non–Candida albicans species
is increasing, and among these candidiasis-causing agents,
Candida krusei, which is an opportunistic pathogen isolated
in some medical centers, can cause serious infections in
susceptible patients.16 Those infections are difficult to treat
owing to their reduced susceptibility to common antifungal
agents. Another important encapsulated yeast-like fungus is
Cryptococcus neoformans, responsible for infectious dis-
eases in patients with AIDS.17 As far as we know, there
are no studies that report on the action of honey against
C. neoformans and C. krusei.
The detailed characterization of the different honey types
existent in Portugal is important because this country is
recognized as having nine protected ‘‘denomination of ori-
gin’’ regions for honey, from a total of 18 in the European
Union.18 Heather honey is characterized by its dark brown
color, strong flavor, and a slightly salty taste, which is
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produced in Portugal from Erica sp., whereas in Spain and
France it comes from either the Calluna or Erica sp. The
Ericaceae family is often used in folk medicine as an al-
ternative therapeutic tool to treat hyperlipidemia, as a
diuretic, astringent, or antiseptic, and in the treatment of
urinary infections.19–21
The aim of this short publication is to assess the
in vitro antifungal properties of Portuguese organic hea-




Honeys (n = 89) were collected in 2008 from various
beekeeping organic explorations in the North of Portugal.
Even though the beekeepers themselves, according to the
best of their knowledge and the location of hives, declared
their honey as monofloral heather honey, all the samples
were subjected to pollen analysis by the Erdtman acetolysis
method; these are described in detail in a previous publi-
cation.22 Results from the quantitative pollen analysis
showed that the samples analyzed always had Erica sp. as
the predominant pollen (at least 45%). Amount per sample
varied between 59% and 72%, with the mean value being
69% and having an SD of 4%. Pollen grains of Lavandulla
sp., Prunus sp., and Echium sp. were found in all honey
samples (100%) with mean values of 14%, 11%, and 6%,
respectively.
Control
A synthetic honey solution with a carbohydrate compo-
sition similar to that of natural honey was used to determine
whether inhibitory effects were due to the sugar content of
the honey samples: 100 g was prepared by dissolving 1.5 g
of sucrose, 7.5 g of maltose, 40.5 g of d-fructose, and 33.5 g
of d-glucose in 17 mL of sterile, deionized water. This
highly viscous solution was kept refrigerated at 4C when
not in use.
Microorganisms and culture conditions
Microorganisms labeled CECT were obtained from the
Spanish Type Culture Collection of Valencia University,
Valencia, Spain, whereas microorganisms labeled ESA
were strains clinically isolated in the Centro Hospitalario do
Nordeste E.P.E. of Braganc¸a, Portugal, and identified in the
Microbiology Laboratory of the Polytechnic Institute of
Braganc¸a. The fungal strains used were C. albicans (CECT
1394), C. krusei (ESA 11), and C. neoformans (ESA 3).
Microorganisms were cultured aerobically at 30C on sterile
yeast peptone dextrose medium containing 2% (w/vol)
glucose, 1% (w/vol) peptone, 1.5% (w/vol) agar, and 0.5%
(w/vol) yeast extract. Before experimental use, cultures
from solid medium were subcultured in liquid medium,
incubated, and used as the source of inocula for each
experiment.
Test assays for antifungal activity
Before the test assays for antifungal activity, the honey
samples were pasteurized according to the technique of
Becker et al.23 Erlenmeyer flasks (150 mL) with 50 mL of
yeast peptone dextrose medium were inoculated with the
yeast suspension (108 colony-forming units/mL), and each
concentration of honey over a range of 0% to 60% (wt/vol)
to be tested was added. Incubation was carried out for 2 days
at 37C in a rotary shaker at 150 rpm.
The specific growth rate (l) values of yeast cultures were
monitored by measuring optical density at 640 nm in a
ultraviolet–visible spectrophotometer and were calculated
by least-squares fitting to the linear part of the semilog
growth plot. The concentration that inhibited 10% of yeast
growth (Xmin) and the concentration that inhibited 90% of
yeast growth (Xmax) were determined by linear regression
analysis. A more detailed presentation of this method has
been previously reported.24
In the analysis involving synthetic honey, the same
methodology was followed, replacing the heather honey by
the same concentrations of synthetic honey and treating as
described above. All heather and synthetic honey samples
were analyzed during the same time period by three dif-
ferent analysts to ensure uniform conditions and compara-
bility.
RESULTS AND DISCUSSION
Different concentrations of heather honey (10–60%) were
screened for their antifungal activity against C. albicans, C.
neoformans, and C. krusei. A synthetic honey solution was
also tested to determine activity attributable to sugars. The l
for fungi was determined, and results are presented in
b F1Figure 1. The results showed that the increase of heather
honey concentrations caused a decrease in l for all organ-
isms studied. The Xmin and Xmax were determined by linear
regression analysis and are shown in bT1Table 1. Xmin values
ranged from 20.5% for C. albicans to 13.5% for C. krusei to
17.1% for C. neoformans, with C. krusei being the most
susceptible to honey because growth inhibition is reached at
the minimum level. Moreover, according to the Xmax ob-
tained, C. krusei was the most susceptible to negative effects
of the tested solutions. The presence of heather honey in the
C. krusei culture medium at concentrations above 60% (wt/
vol) inhibited 90% of the yeast growth (Xmax). In contrast,
the same concentration of synthetic honey was established
as Xmin for C. krusei, whereas C. albicans and C. neofor-
mans were more resistant. More important is that this is the
first report testing the in vitro antifungal potential of honey
against C. krusei. Antifungal activity against C. krusei, in
particular, is noteworthy given the acquired and intrinsic
resistance of this species to fluconazole.16
Our data suggest that the honey mechanism for fungal
growth inhibition is not related to the osmotic shock derived
from the presence of sugar in the culture medium. In the
same way, previous reports have demonstrated that in-
creased honey concentrations resulted in reduced growth of
C. albicans, namely, 29.4% inhibition of the growth was
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verified in the presence of wasbessie honey at concentra-
tions of 25%.4 The minimum inhibitory concentration of
honeys against isolates of Candida species (C. albicans,
Candida glabrata, and Candida dubliniensis) would be
achievable in a clinical setting,5 with C. dubliniensis being
more susceptible to the osmotic effect of all honeys and to
the antifungal effects of Jarrah honey. However, in contrast,
previous studies with different types of honey, tested at
several concentrations ranging from 0.1% to 20%2 and from
25 to 100%,25 revealed that the growth of C. albicans was
not inhibited by the honeys.
Several factors may influence the antifungal activity of
honey. These factors include its physicochemical properties,
botanical origin, entomological origin, and symbioses with
beneficial bacteria. The literature reviewed shows us that
research on monofloral Erica sp. honeys is mainly focused
on their physicochemical and palynological features,26–29
the assessment of the possible markers for their floral ori-
gin,30 the development of an electronic tongue for heather
honey classification,31 and, more recently, the antioxidant
and antibacterial properties of the phenolic compounds
found in Portuguese heather honey, demonstrated with
promising results.32
The healing properties of honey depend largely on the
floral source that nourishes the honeybees. For example,
DeMera and Angert33 reported that honeys from different
phytogeographic regions varied in their ability to inhibit the
growth of yeasts, suggesting that botanical origin plays an
important role in influencing the antifungal activity. Erica
sp. contain many active substances such as flavonoids, an-
thocyanidols, coumarins, and triterpenic compounds, which
are expected to be found in heather honey. Moreover, major
compounds of Erica sp. flowers have been isolated and
proved to have antimicrobial34 and antiulcer35 activities as
well as cytotoxic and anticarcinogenic properties.36 Analy-
sis of phenolic compounds in heather honey samples
showed that about 14 phenolic compounds could be iden-
tified (five flavonoids and nine phenolic acids) and that the
phenolic pattern of honey contains protocatechic acid, p-
hydroxybenzoic acid, caffeic acid, chlorogenic acid, vanillic
acid, p-coumaric acid, benzoic acid, chrysin, and cinnamic
acid, as well as the flavonoids naringenin, kaempferol,
apigenin, pinocembrin, and ellagic acid.37 In plants, ellagic
acid is present in the form of ellagitannin, which is ellagic
acid bound to a sugar molecule. Ellagitannins are hydro-
lyzed by bee enzymes to yield ellagic acid, the bioactive
agent that offers protection. Although recent work shows
that there are other compounds present, which could not be
identified because of lack of availability of standard
compounds,32 it has been concluded that ellagic acid and
FIG. 1. Fungal growth rate (l, in h - 1) in the presence of heather
honey and synthetic honey at different concentrations (wt/vol).
Table 1. Heather Honey and Synthetic Honey
Concentrations That Inhibited 10% and 90%
of Yeast Growth
Concentration (%, wt/vol)
Heather honey Synthetic honey
Yeast Xmin Xmax Xmin Xmax
C. albicans 20.5 > 60.0 > 60.0 —
C. krusei 13.5 60.0 60.0 —
C. neoformans 17.1 > 60.0 > 60.0 —
Xmin and Xmax represent concentrations that inhibited 10% and 90%,
respectively, of yeast growth.
ANTIFUNGAL EFFECTS OF HEATHER HONEY 3
JMF-2010-0211-ver9-Feas_1P.3d 04/21/11 12:12pm Page 3
myricetin-30-methylether (which have not been identifying
in any of the monofloral honeys investigated so far) seem to
be potential markers for the floral origin of heather hon-
ey.32,38,39 Therefore, different honey properties were ex-
pected because the composition of active compounds in
honey from different locations should be different.
In conclusion, the antifungal effect of organic heather
honey was evaluated in culture medium containing different
concentrations of honey. What the data suggest is that the
component in the heather honey responsible for the ob-
served antifungal in vitro properties is not sugar based.
Although the therapeutic action of honey has been given
some attention by researchers, studies have only been done
by screening raw honey samples. The use of novel and
powerful high-throughput techniques that currently are used
in drug development will be of value to ascertain the med-
ical properties of honey. Once the compound’s structure is
known, the chemical can serve as a prototype or "lead
compound" for designing more effective therapeutic agents
of similar chemical structure.
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